285 related articles for article (PubMed ID: 32589943)
21. Mitochondrial UQCC3 Modulates Hypoxia Adaptation by Orchestrating OXPHOS and Glycolysis in Hepatocellular Carcinoma.
Yang Y; Zhang G; Guo F; Li Q; Luo H; Shu Y; Shen Y; Gan J; Xu L; Yang H
Cell Rep; 2020 Nov; 33(5):108340. PubMed ID: 33147459
[TBL] [Abstract][Full Text] [Related]
22. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
[TBL] [Abstract][Full Text] [Related]
23. Hydrogen peroxide inducible clone-5 mediates reactive oxygen species signaling for hepatocellular carcinoma progression.
Wu JR; Hu CT; You RI; Pan SM; Cheng CC; Lee MC; Wu CC; Chang YJ; Lin SC; Chen CS; Lin TY; Wu WS
Oncotarget; 2015 Oct; 6(32):32526-44. PubMed ID: 26416447
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
26. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial fission forms a positive feedback loop with cytosolic calcium signaling pathway to promote autophagy in hepatocellular carcinoma cells.
Huang Q; Cao H; Zhan L; Sun X; Wang G; Li J; Guo X; Ren T; Wang Z; Lyu Y; Liu B; An J; Xing J
Cancer Lett; 2017 Sep; 403():108-118. PubMed ID: 28624623
[TBL] [Abstract][Full Text] [Related]
28. Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.
Lee D; Zhang MS; Tsang FH; Bao MH; Xu IM; Lai RK; Chiu DK; Tse AP; Law CT; Chan CY; Yuen VW; Chui NN; Ng IO; Wong CM; Wong CC
Hepatology; 2021 Aug; 74(2):776-796. PubMed ID: 33619771
[TBL] [Abstract][Full Text] [Related]
29. Eukaryotic translation initiation factor 5A2 regulates the migration and invasion of hepatocellular carcinoma cells via pathways involving reactive oxygen species.
Liu RR; Lv YS; Tang YX; Wang YF; Chen XL; Zheng XX; Xie SZ; Cai Y; Yu J; Zhang XN
Oncotarget; 2016 Apr; 7(17):24348-60. PubMed ID: 27028999
[TBL] [Abstract][Full Text] [Related]
30. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Huang X; Gan G; Wang X; Xu T; Xie W
Autophagy; 2019 Jul; 15(7):1258-1279. PubMed ID: 30786811
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone I induces cell apoptosis by reactive oxygen species-mediated endoplasmic reticulum stress and by suppressing p53/DRAM-mediated autophagy in human hepatocellular carcinoma.
Liu X; Liu J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):488-497. PubMed ID: 32013613
[TBL] [Abstract][Full Text] [Related]
32. The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.
Guo X; Noguchi H; Ishii N; Homma T; Hamada T; Hiraki T; Zhang J; Matsuo K; Yokoyama S; Ishibashi H; Fukushige T; Kanekura T; Fujii J; Uramoto H; Tanimoto A; Yamada S
Antioxid Redox Signal; 2019 Apr; 30(10):1271-1284. PubMed ID: 29687726
[TBL] [Abstract][Full Text] [Related]
33. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma.
Liu MX; Jin L; Sun SJ; Liu P; Feng X; Cheng ZL; Liu WR; Guan KL; Shi YH; Yuan HX; Xiong Y
Oncogene; 2018 Mar; 37(12):1637-1653. PubMed ID: 29335519
[TBL] [Abstract][Full Text] [Related]
34. PRMT6 deficiency induces autophagy in hostile microenvironments of hepatocellular carcinoma tumors by regulating BAG5-associated HSC70 stability.
Che N; Ng KY; Wong TL; Tong M; Kau PW; Chan LH; Lee TK; Huen MS; Yun JP; Ma S
Cancer Lett; 2021 Mar; 501():247-262. PubMed ID: 33186656
[TBL] [Abstract][Full Text] [Related]
35. O-GlcNAcylation on Rab3A attenuates its effects on mitochondrial oxidative phosphorylation and metastasis in hepatocellular carcinoma.
Wu W; Zheng X; Wang J; Yang T; Dai W; Song S; Fang L; Wang Y; Gu J
Cell Death Dis; 2018 Sep; 9(10):970. PubMed ID: 30237463
[TBL] [Abstract][Full Text] [Related]
36. Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression.
Shen J; Chen M; Lee D; Law CT; Wei L; Tsang FH; Chin DW; Cheng CL; Lee JM; Ng IO; Wong CC; Wong CM
Gut; 2020 Feb; 69(2):329-342. PubMed ID: 31439637
[TBL] [Abstract][Full Text] [Related]
37. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
38. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
[TBL] [Abstract][Full Text] [Related]
39. Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma.
Bartolini D; Dallaglio K; Torquato P; Piroddi M; Galli F
Transl Res; 2018 Mar; 193():54-71. PubMed ID: 29274776
[TBL] [Abstract][Full Text] [Related]
40. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
